Delivery Order SPE2DB20D7059-SPE2DB24FPYS4

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of DAPTACEL DTAP vaccine in 0.5mL doses. The $1,159.16 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical division and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which does not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPTACEL DTAP vaccine in 0.5 ml doses, with a ceiling value of $1,603.90 and a completion date of May 29, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) has awarded a $1,726.42 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 0.5 mL INFANRIX DTAP syringes. This delivery order contract has a completion date of January 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and is headquartered in Conshohocken, Pennsylvania. This delivery order is issued under a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,496.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is to supply 4558171879 ADACEL TDAP VIAL 0.5ML, with a completion date of August 23, 2022. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, including the military. This delivery order is part of a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,842,229 units of the ADACEL TDAP VIAL 0.5ML pharmaceutical product. The $3,831.60 delivery order has a performance period through March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the DAPTACEL DTAP vaccine in 0.5 mL doses. The contract has a firm fixed price of $1,603.90 and a performance period through June 11, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of the DAPTACEL DTAP vaccine. The contract has a ceiling value of $1,239.04 and a firm fixed price pricing type. It is not a set-aside contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,103.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This contract has a completion date of March 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is likely part of a larger indefinite delivery contract (IDC) with DLA valued up...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ADACEL Tdap syringes. The $1,272.40 award has a completion date of March 6, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, notably the Department of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $19,498.82 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc. (also known as Amerisourcebergen). The delivery order is for the supply of 4,564,017,417 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for providing these pharmaceutical products to...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPYS4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DAPTACEL DTAP vaccine with a potential value of $1,536.16. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous prior delivery orders from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division valued at up to $750,000 through May 2024, as well as a single award indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of medications and healthcare materials to military treatment programs and facilities worldwide.

Generated 5/7/24, 11:39 AM